Ascentro is a New Zealand–based PE, debt, and corporate advisory firm partnering with established business owners. Healthcare services is one of many sectors they consider.
About Ascentro Capital Partners
Ascentro Capital Partners is an Auckland-based private equity, debt, and corporate advisory firm operating across New Zealand and Australia. The firm sits in the lower mid-market PE category with healthcare services among the verticals it considers, alongside other established-business sectors.
The stated thesis is partnering with established business owners, including succession transactions, growth equity, and selective co-investments. For healthcare founders, that means Ascentro is most relevant for owner-operated care delivery businesses, tech-enabled health services, allied health platforms, and roll-up opportunities in the Australia and New Zealand market with established cash flow. Portfolio companies are not disclosed in the input record, so founders should ask for the current and historical book during initial conversations to validate sector depth. The transaction types disclosed are lead, co-invest, and growth equity, with company attributes specifying established and cash-flow-positive businesses.
Disclosed check size is $5M to $25M, with typical deals reported as $10M to $50M, deployed at Series B, Series C, and growth. Geography is New Zealand and Australia. This is not venture capital and should not be approached as such. Pre-revenue and early-revenue digital health startups are out of scope; founders with multiple million NZD or AUD of revenue, predictable cash flow, and a credible growth thesis are in scope.
Named team members are not provided in the input record; the who-we-are page on the firm’s website is the right starting point.
Approach Ascentro when you operate a profitable healthcare services or tech-enabled services business in New Zealand or Australia, are considering succession or growth equity, and want a regional financial partner rather than a Sydney or Melbourne mega-fund. They are not the right call for early-stage venture capital, US-domiciled companies, or pre-revenue digital health bets. The right entry is via a New Zealand or Australian healthcare M&A advisor, an accountant or banker familiar with the firm, or a portfolio company founder. When pitching, lead with cash flow quality, owner-operator dynamics, and the specific transaction structure you envision, because Ascentro engages on the deal shape as much as on the underlying business. Bring three years of clean management accounts before requesting a meeting.
Founder reviews
Other portfolio companies
Companies in Ascentro Capital Partners's portfolio not currently in our directory.
- General Capital (GEN)
- Amplifi Holdings
- Provincial Education Group
- Mint Asset Management
- ICIB Brokerweb
Pitch / review this investor
Have you raised from Ascentro Capital Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).